
8th ACE Clinical Trials Summit London 2027
About 8th ACE Clinical Trials Summit London 2027
The 8th ACE Clinical Trials Summit (ACTS 2027) convenes global leaders, clinical trial directors, heads of clinical operations, and regulatory strategists in London for two intensive days of networking, high-level presentations, and pre-scheduled 1-to-1 business meetings.
As clinical development grows increasingly complex with decentralized models, advanced AI integration, and patient-centric recruitment paradigms, ACTS 2027 offers an exclusive setting to benchmark strategies, forge key vendor alliances, and unlock commercial growth.
Why Attend ACTS 2027
Five reasons senior industry leaders choose our curated summit model.

Roadmap Planning & Strategic Forecasting

Targeted High-Impact Executive Networking

Unmatched Cross-Industry Knowledge Transfer

Significantly Shorter B2B Sales Cycles

Cost-Effective Business Development
Solutions at ACTS 2027
Who Will Attend
The summit brings together key decision-makers and C-level executives from pharmaceuticals, biotechnology, CROs, academic trial units, and digital health technology providers.
Advisory Board Members
Conference Chairpersons

Salomea Guchmazashvili
National Consultant
WHO Country Office in Georgia

Caz Canavan
Clinical Development Medical Director
Novartis
Distinguished Speaker Panel
Industry pioneers delivering actionable insights and regulatory case studies.

Sarah Scorer
Director of Clinical Innovation
GSK Research

Szymon Komorowski
Pharma & Life Sciences Advisor
deepsense.ai

Dr Daphne Hazell MRCGP
CEO & Founder
Primary Care Research Alliance

Nurcan Coskun
Director, Program Management Leader
Johnson & Johnson

Claire Herholdt
VP, Clinical Operations
Levicept

Lorna Pender
Chief Patient Advocate
Rare Disease Alliance

Gabriel Wong
Senior Medical Director
AstraZeneca

Simmi Wiggins
Senior Marketing Director
Sanofi

Thierry Schulmann
Director of Cold Chain Logistics
EuroLogistics Pharma

Matthias Rohrbeck
VP of Digital Innovations
Roche Diagnostics

Kiki Diorgu
Trial Protocol Design Specialist
Roche Diagnostics

Shikta Das
Director of Biostatistics
StatsCore Global
Attendee Demographics & Breakdown
Conference Themes & Agenda
Explore key track topics, interactive roundtables, and keynote panels.
Day 01
14th April 2027- Future of Clinical Trials in Age of Advanced AI
- Clinical Trial Safety Monitoring & Real-World Evidence
- Operational Realities of Advanced Therapies Trials
- Managing Decentralized and Hybrid Clinical Trials
- Clinical Trial Design and Adaptive Operations
- Clinical Data Management: What does the future hold?
Day 02
15th April 2027- Implementing Digital Health Technologies in Clinical Trials
- Regulatory Aspects of Digital Health Technology Use
- Enhancing Patient Engagement Across the Trial Lifecycle
- Clinical Operations in Next Generation Trials
- Future of Patient Recruitment and Retention Strategies
- Rare Disease Clinical Trials: Innovation and Site Feasibility
Our Official Sponsors.
Leading pharmaceutical enterprises, clinical research organizations, and biotech innovators empowering executive dealmaking.
Participating Industry Leaders.
Senior executives, clinical directors, and R&D delegations from the world's foremost biopharmaceutical enterprises participating across our summit series.
50+ Global Biopharma Represented
Multinational Fortune 500 pharmaceutical titans and breakthrough clinical-stage biotechs.
Senior Decision Makers
Over 80% Vice Presidents, Global Heads of Clinical Operations, and Director-level executive attendees.
Pre-Qualified 1-on-1 Dealmaking
Targeted commercial intelligence meetings and closed-door Chatham House rule leadership roundtables.
International Delegations
Cross-border clinical leaders convening across the UK, Europe, North America & Asia-Pacific.

Media Partners.
International publishing networks, industry directories, and conference portals broadcasting summit breakthroughs worldwide.
VENUE : London, United Kingdom
Situated in the heart of London, The Leonardo Hotel provides state-of-the-art conference facilities, luxury accommodation, and seamless international transport links.






















